Global EPA and DHA Market Growth 2026-2032
The global EPA and DHA market size is predicted to grow from US$ 2357 million in 2025 to US$ 3432 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
In 2025, global EPA and DHA production reached approximately 135,318 tons, with a average price of 17.8 USD/kg.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are two long-chain Omega-3 polyunsaturated fatty acids that are vital for human health. They are primarily found in deep-sea cold-water fish, shellfish, and microalgae. Since the human body converts plant-derived fatty acids (ALA) into EPA and DHA with extremely low efficiency, obtaining them directly through diet or nutritional supplements remains the only practical means of maintaining adequate levels within the body.
EPA and DHA are long-chain omega-3 polyunsaturated fatty acids. EPA refers to eicosapentaenoic acid, while DHA refers to docosahexaenoic acid. They are key functional lipids associated with cardiovascular health, neurodevelopment, retinal function, inflammatory modulation, and lipid metabolism. In industrial terms, EPA and DHA are not simply equivalent to generic fish oil; they refer to nutritional ingredients, food additives, pharmaceutical raw materials, and functional health products produced from fish oil, algal oil, krill oil, and certain marine by-product oils through refining, concentration, purification, esterification, re-esterification, microencapsulation, or dosage-form processing. Commercial forms include refined oils, concentrated oils, ethyl ester oils, triglyceride oils, powders, emulsions, softgels, liquid formulations, and pharmaceutical-grade high-purity EPA/DHA ingredients. Major applications include dietary supplements, infant formula, functional food and beverages, clinical nutrition, prescription omega-3 products, and pet nutrition.
The EPA and DHA industry is mainly built around two production models: marine oil extraction and concentration, and microalgae fermentation followed by oil extraction and refining. The marine route uses sources such as Peruvian anchovy, sardine, tuna by-products, mackerel, and cod liver oil, followed by crude oil sourcing, degumming, deacidification, bleaching, deodorization, molecular distillation, esterification/re-esterification, concentration, and antioxidant stabilization to produce refined fish oil, medium-to-high concentration EPA/DHA oils, and premium rTG products. The algal route is built on microalgae strains, fermentation tanks, culture media, extraction, and refining, making it suitable for vegan, sustainable, infant nutrition, and premium supplement applications. Industry gross margins vary significantly: low-concentration refined fish oils and commodity-grade materials are typically around 12%?25%; medium-to-high concentration oils, powders, and customized formulations are around 25%?45%; pharmaceutical-grade high-purity EPA, proprietary algal oils, and high-concentration rTG products can reach around 40%?65%. Actual profitability is influenced by fish oil raw material prices, Peruvian anchovy seasons, oxidative stability, certification systems, regulatory registrations, and long-term customer contracts. The upstream chain focuses on marine resources, algal strains, and fermentation inputs; midstream competition centers on purification, concentration efficiency, odor control, contaminant management, batch consistency, and compliance documentation; downstream demand is driven by supplement brands, infant formula companies, pharmaceutical firms, functional food manufacturers, pet nutrition brands, and CDMO customers.
Market Development Opportunities & Main Driving Factors
The core market opportunity for EPA and DHA is created by the convergence of evidence-based nutrition, sustainable sourcing, and premium dosage-form innovation. Rising consumer awareness of cardiovascular management, maternal and infant nutrition, cognitive health, eye health, and proactive wellness is shifting EPA/DHA from traditional fish oil supplementation into a high-value functional lipid platform. Algal EPA/DHA is particularly attractive because it is independent of marine fisheries and fits vegan, clean-label, sustainable sourcing, and premium infant nutrition requirements. Leading companies are also moving from conventional fish oil toward proprietary algal oils, high-concentration oils, customized formulations, and pharmaceutical-grade ingredients. With the ingredient market returning to growth in 2024, high potency, low odor, smaller serving size, traceability, and compliant labeling are becoming major levers for brand differentiation.
Market Challenges, Risks, & Restraints
The main risks lie in raw material cyclicality, price transmission, quality compliance, and the boundaries of health claims. Fish oil supply is highly exposed to Peruvian anchovy seasons, El Ni?o events, regional quotas, and changes in fatty acid profiles, and the supply volatility after 2023 has made inventory control, long-term procurement, and multi-source sourcing more important. Although fish oil production recovered in 2024, regional declines and pricing pressure still affect margin stability. EPA/DHA is also a nutrition ingredient with strong consumer recognition and high regulatory sensitivity, requiring strict control of contaminants, oxidation indicators, heavy metals, batch traceability, label accuracy, and health claims. For smaller players, weaker raw material bargaining power, limited concentration technology, rising certification costs, and price pressure from downstream brands will continue to compress profitability in low-end products.
Downstream Demand Trends
Downstream demand is moving from single-format fish oil softgels toward multi-scenario, precise-dosage, and better-sensory formulations. Dietary supplements remain one of the largest applications, but growth is shifting toward high-concentration EPA/DHA, smaller softgels, liquid drops, gummies, emulsions, ready-to-drink products, clinical nutrition, and pet health. Infant formula and maternal nutrition emphasize stable DHA supply and high safety standards, while the pharmaceutical segment focuses on high-purity EPA or specific EPA/DHA ratios. Future competition will no longer be determined only by oil price per kilogram; it will depend on sustainability, dosage-form compatibility, odor control, oxidative stability, regulatory documentation, and co-development capability with customers. Integrated producers with algal fermentation, fish oil concentration, pharmaceutical-grade registration, microencapsulation, and finished dosage-form capabilities are positioned to gain stronger pricing power in premium nutrition and professional health markets.
LP Information, Inc. (LPI) ' newest research report, the ?EPA and DHA Industry Forecast? looks at past sales and reviews total world EPA and DHA sales in 2025, providing a comprehensive analysis by region and market sector of projected EPA and DHA sales for 2026 through 2032. With EPA and DHA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EPA and DHA industry.
This Insight Report provides a comprehensive analysis of the global EPA and DHA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EPA and DHA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global EPA and DHA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EPA and DHA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EPA and DHA.
This report presents a comprehensive overview, market shares, and growth opportunities of EPA and DHA market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global EPA and DHA market?
What factors are driving EPA and DHA market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EPA and DHA market opportunities vary by end market size?
How does EPA and DHA break out by Type, by Application?
In 2025, global EPA and DHA production reached approximately 135,318 tons, with a average price of 17.8 USD/kg.
EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are two long-chain Omega-3 polyunsaturated fatty acids that are vital for human health. They are primarily found in deep-sea cold-water fish, shellfish, and microalgae. Since the human body converts plant-derived fatty acids (ALA) into EPA and DHA with extremely low efficiency, obtaining them directly through diet or nutritional supplements remains the only practical means of maintaining adequate levels within the body.
EPA and DHA are long-chain omega-3 polyunsaturated fatty acids. EPA refers to eicosapentaenoic acid, while DHA refers to docosahexaenoic acid. They are key functional lipids associated with cardiovascular health, neurodevelopment, retinal function, inflammatory modulation, and lipid metabolism. In industrial terms, EPA and DHA are not simply equivalent to generic fish oil; they refer to nutritional ingredients, food additives, pharmaceutical raw materials, and functional health products produced from fish oil, algal oil, krill oil, and certain marine by-product oils through refining, concentration, purification, esterification, re-esterification, microencapsulation, or dosage-form processing. Commercial forms include refined oils, concentrated oils, ethyl ester oils, triglyceride oils, powders, emulsions, softgels, liquid formulations, and pharmaceutical-grade high-purity EPA/DHA ingredients. Major applications include dietary supplements, infant formula, functional food and beverages, clinical nutrition, prescription omega-3 products, and pet nutrition.
The EPA and DHA industry is mainly built around two production models: marine oil extraction and concentration, and microalgae fermentation followed by oil extraction and refining. The marine route uses sources such as Peruvian anchovy, sardine, tuna by-products, mackerel, and cod liver oil, followed by crude oil sourcing, degumming, deacidification, bleaching, deodorization, molecular distillation, esterification/re-esterification, concentration, and antioxidant stabilization to produce refined fish oil, medium-to-high concentration EPA/DHA oils, and premium rTG products. The algal route is built on microalgae strains, fermentation tanks, culture media, extraction, and refining, making it suitable for vegan, sustainable, infant nutrition, and premium supplement applications. Industry gross margins vary significantly: low-concentration refined fish oils and commodity-grade materials are typically around 12%?25%; medium-to-high concentration oils, powders, and customized formulations are around 25%?45%; pharmaceutical-grade high-purity EPA, proprietary algal oils, and high-concentration rTG products can reach around 40%?65%. Actual profitability is influenced by fish oil raw material prices, Peruvian anchovy seasons, oxidative stability, certification systems, regulatory registrations, and long-term customer contracts. The upstream chain focuses on marine resources, algal strains, and fermentation inputs; midstream competition centers on purification, concentration efficiency, odor control, contaminant management, batch consistency, and compliance documentation; downstream demand is driven by supplement brands, infant formula companies, pharmaceutical firms, functional food manufacturers, pet nutrition brands, and CDMO customers.
Market Development Opportunities & Main Driving Factors
The core market opportunity for EPA and DHA is created by the convergence of evidence-based nutrition, sustainable sourcing, and premium dosage-form innovation. Rising consumer awareness of cardiovascular management, maternal and infant nutrition, cognitive health, eye health, and proactive wellness is shifting EPA/DHA from traditional fish oil supplementation into a high-value functional lipid platform. Algal EPA/DHA is particularly attractive because it is independent of marine fisheries and fits vegan, clean-label, sustainable sourcing, and premium infant nutrition requirements. Leading companies are also moving from conventional fish oil toward proprietary algal oils, high-concentration oils, customized formulations, and pharmaceutical-grade ingredients. With the ingredient market returning to growth in 2024, high potency, low odor, smaller serving size, traceability, and compliant labeling are becoming major levers for brand differentiation.
Market Challenges, Risks, & Restraints
The main risks lie in raw material cyclicality, price transmission, quality compliance, and the boundaries of health claims. Fish oil supply is highly exposed to Peruvian anchovy seasons, El Ni?o events, regional quotas, and changes in fatty acid profiles, and the supply volatility after 2023 has made inventory control, long-term procurement, and multi-source sourcing more important. Although fish oil production recovered in 2024, regional declines and pricing pressure still affect margin stability. EPA/DHA is also a nutrition ingredient with strong consumer recognition and high regulatory sensitivity, requiring strict control of contaminants, oxidation indicators, heavy metals, batch traceability, label accuracy, and health claims. For smaller players, weaker raw material bargaining power, limited concentration technology, rising certification costs, and price pressure from downstream brands will continue to compress profitability in low-end products.
Downstream Demand Trends
Downstream demand is moving from single-format fish oil softgels toward multi-scenario, precise-dosage, and better-sensory formulations. Dietary supplements remain one of the largest applications, but growth is shifting toward high-concentration EPA/DHA, smaller softgels, liquid drops, gummies, emulsions, ready-to-drink products, clinical nutrition, and pet health. Infant formula and maternal nutrition emphasize stable DHA supply and high safety standards, while the pharmaceutical segment focuses on high-purity EPA or specific EPA/DHA ratios. Future competition will no longer be determined only by oil price per kilogram; it will depend on sustainability, dosage-form compatibility, odor control, oxidative stability, regulatory documentation, and co-development capability with customers. Integrated producers with algal fermentation, fish oil concentration, pharmaceutical-grade registration, microencapsulation, and finished dosage-form capabilities are positioned to gain stronger pricing power in premium nutrition and professional health markets.
LP Information, Inc. (LPI) ' newest research report, the ?EPA and DHA Industry Forecast? looks at past sales and reviews total world EPA and DHA sales in 2025, providing a comprehensive analysis by region and market sector of projected EPA and DHA sales for 2026 through 2032. With EPA and DHA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EPA and DHA industry.
This Insight Report provides a comprehensive analysis of the global EPA and DHA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EPA and DHA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global EPA and DHA market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EPA and DHA and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EPA and DHA.
This report presents a comprehensive overview, market shares, and growth opportunities of EPA and DHA market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- EPA
- DHA
- Fish Oil EPA and DHA
- Algae Oil EPA and DHA
- Others
- Food Grade
- Pharma Grade
- Feed Grade
- Dietary Supplements
- Fortified Food and Beverages
- Infant Formula
- Pharmaceuticals
- Pet Food
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- dsm-firmenich
- KD Pharma
- Croda
- BASF
- Yuwang Pharma
- Corbion
- GC Rieber VivoMega
- Pelagia (EPAX)
- Golden Omega
- TASA
- KinOmega Biopharm
- Omega Protein
- Huatai Phrama
- AlaskOmega (Wiley Companies)
- Jiangsu Auqi Marine Biotechnology
- Roquette
- Polaris
- Solutex
- Sinomega Biotech Engineering
- Xinzhou Marine Biological Products
- ADM
- Nu-Mega (Clover)
- Guangdong Runke Bioengineering
- Nissui
- Cabio Biotech
- Skuny Bioscience
- Fermentalg
- Renpu Pharmaceuticals
- Xiamen HUISON Biotech
- Xiamen Kingdomway
- Algarithm
- Hubei Fuxing Biological Technology
What is the 10-year outlook for the global EPA and DHA market?
What factors are driving EPA and DHA market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EPA and DHA market opportunities vary by end market size?
How does EPA and DHA break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global EPA and DHA Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for EPA and DHA by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for EPA and DHA by Country/Region, 2021, 2025 & 2032
2.2 EPA and DHA Segment by Type
2.2.1 EPA
2.2.2 DHA
2.2.3 EPA and DHA Sales by Type
2.2.3.1 Global EPA and DHA Sales Market Share by Type (2021-2026)
2.2.3.2 Global EPA and DHA Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global EPA and DHA Sale Price by Type (2021-2026)
2.3 EPA and DHA Segment by Source
2.3.1 Fish Oil EPA and DHA
2.3.2 Algae Oil EPA and DHA
2.3.3 Others
2.3.4 EPA and DHA Sales by Source
2.3.4.1 Global EPA and DHA Sales Market Share by Source (2021-2026)
2.3.4.2 Global EPA and DHA Revenue and Market Share by Source (2021-2026)
2.3.4.3 Global EPA and DHA Sale Price by Source (2021-2026)
2.4 EPA and DHA Segment by Grade
2.4.1 Food Grade
2.4.2 Pharma Grade
2.4.3 Feed Grade
2.4.4 EPA and DHA Sales by Grade
2.4.4.1 Global EPA and DHA Sales Market Share by Grade (2021-2026)
2.4.4.2 Global EPA and DHA Revenue and Market Share by Grade (2021-2026)
2.4.4.3 Global EPA and DHA Sale Price by Grade (2021-2026)
2.5 EPA and DHA Segment by Application
2.5.1 Dietary Supplements
2.5.2 Fortified Food and Beverages
2.5.3 Infant Formula
2.5.4 Pharmaceuticals
2.5.5 Pet Food
2.5.6 Others
2.5.7 EPA and DHA Sales by Application
2.5.7.1 Global EPA and DHA Sale Market Share by Application (2021-2026)
2.5.7.2 Global EPA and DHA Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global EPA and DHA Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global EPA and DHA Breakdown Data by Company
3.1.1 Global EPA and DHA Annual Sales by Company (2021-2026)
3.1.2 Global EPA and DHA Sales Market Share by Company (2021-2026)
3.2 Global EPA and DHA Annual Revenue by Company (2021-2026)
3.2.1 Global EPA and DHA Revenue by Company (2021-2026)
3.2.2 Global EPA and DHA Revenue Market Share by Company (2021-2026)
3.3 Global EPA and DHA Sale Price by Company
3.4 Key Manufacturers EPA and DHA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers EPA and DHA Product Location Distribution
3.4.2 Players EPA and DHA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EPA AND DHA BY GEOGRAPHIC REGION
4.1 World Historic EPA and DHA Market Size by Geographic Region (2021-2026)
4.1.1 Global EPA and DHA Annual Sales by Geographic Region (2021-2026)
4.1.2 Global EPA and DHA Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic EPA and DHA Market Size by Country/Region (2021-2026)
4.2.1 Global EPA and DHA Annual Sales by Country/Region (2021-2026)
4.2.2 Global EPA and DHA Annual Revenue by Country/Region (2021-2026)
4.3 Americas EPA and DHA Sales Growth
4.4 APAC EPA and DHA Sales Growth
4.5 Europe EPA and DHA Sales Growth
4.6 Middle East & Africa EPA and DHA Sales Growth
5 AMERICAS
5.1 Americas EPA and DHA Sales by Country
5.1.1 Americas EPA and DHA Sales by Country (2021-2026)
5.1.2 Americas EPA and DHA Revenue by Country (2021-2026)
5.2 Americas EPA and DHA Sales by Type (2021-2026)
5.3 Americas EPA and DHA Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC EPA and DHA Sales by Region
6.1.1 APAC EPA and DHA Sales by Region (2021-2026)
6.1.2 APAC EPA and DHA Revenue by Region (2021-2026)
6.2 APAC EPA and DHA Sales by Type (2021-2026)
6.3 APAC EPA and DHA Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe EPA and DHA by Country
7.1.1 Europe EPA and DHA Sales by Country (2021-2026)
7.1.2 Europe EPA and DHA Revenue by Country (2021-2026)
7.2 Europe EPA and DHA Sales by Type (2021-2026)
7.3 Europe EPA and DHA Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa EPA and DHA by Country
8.1.1 Middle East & Africa EPA and DHA Sales by Country (2021-2026)
8.1.2 Middle East & Africa EPA and DHA Revenue by Country (2021-2026)
8.2 Middle East & Africa EPA and DHA Sales by Type (2021-2026)
8.3 Middle East & Africa EPA and DHA Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of EPA and DHA
10.3 Manufacturing Process Analysis of EPA and DHA
10.4 Industry Chain Structure of EPA and DHA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 EPA and DHA Distributors
11.3 EPA and DHA Customer
12 WORLD FORECAST REVIEW FOR EPA AND DHA BY GEOGRAPHIC REGION
12.1 Global EPA and DHA Market Size Forecast by Region
12.1.1 Global EPA and DHA Forecast by Region (2027-2032)
12.1.2 Global EPA and DHA Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global EPA and DHA Forecast by Type (2027-2032)
12.7 Global EPA and DHA Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 dsm-firmenich
13.1.1 dsm-firmenich Company Information
13.1.2 dsm-firmenich EPA and DHA Product Portfolios and Specifications
13.1.3 dsm-firmenich EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 dsm-firmenich Main Business Overview
13.1.5 dsm-firmenich Latest Developments
13.2 KD Pharma
13.2.1 KD Pharma Company Information
13.2.2 KD Pharma EPA and DHA Product Portfolios and Specifications
13.2.3 KD Pharma EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 KD Pharma Main Business Overview
13.2.5 KD Pharma Latest Developments
13.3 Croda
13.3.1 Croda Company Information
13.3.2 Croda EPA and DHA Product Portfolios and Specifications
13.3.3 Croda EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Croda Main Business Overview
13.3.5 Croda Latest Developments
13.4 BASF
13.4.1 BASF Company Information
13.4.2 BASF EPA and DHA Product Portfolios and Specifications
13.4.3 BASF EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BASF Main Business Overview
13.4.5 BASF Latest Developments
13.5 Yuwang Pharma
13.5.1 Yuwang Pharma Company Information
13.5.2 Yuwang Pharma EPA and DHA Product Portfolios and Specifications
13.5.3 Yuwang Pharma EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yuwang Pharma Main Business Overview
13.5.5 Yuwang Pharma Latest Developments
13.6 Corbion
13.6.1 Corbion Company Information
13.6.2 Corbion EPA and DHA Product Portfolios and Specifications
13.6.3 Corbion EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Corbion Main Business Overview
13.6.5 Corbion Latest Developments
13.7 GC Rieber VivoMega
13.7.1 GC Rieber VivoMega Company Information
13.7.2 GC Rieber VivoMega EPA and DHA Product Portfolios and Specifications
13.7.3 GC Rieber VivoMega EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GC Rieber VivoMega Main Business Overview
13.7.5 GC Rieber VivoMega Latest Developments
13.8 Pelagia (EPAX)
13.8.1 Pelagia (EPAX) Company Information
13.8.2 Pelagia (EPAX) EPA and DHA Product Portfolios and Specifications
13.8.3 Pelagia (EPAX) EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pelagia (EPAX) Main Business Overview
13.8.5 Pelagia (EPAX) Latest Developments
13.9 Golden Omega
13.9.1 Golden Omega Company Information
13.9.2 Golden Omega EPA and DHA Product Portfolios and Specifications
13.9.3 Golden Omega EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Golden Omega Main Business Overview
13.9.5 Golden Omega Latest Developments
13.10 TASA
13.10.1 TASA Company Information
13.10.2 TASA EPA and DHA Product Portfolios and Specifications
13.10.3 TASA EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 TASA Main Business Overview
13.10.5 TASA Latest Developments
13.11 KinOmega Biopharm
13.11.1 KinOmega Biopharm Company Information
13.11.2 KinOmega Biopharm EPA and DHA Product Portfolios and Specifications
13.11.3 KinOmega Biopharm EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KinOmega Biopharm Main Business Overview
13.11.5 KinOmega Biopharm Latest Developments
13.12 Omega Protein
13.12.1 Omega Protein Company Information
13.12.2 Omega Protein EPA and DHA Product Portfolios and Specifications
13.12.3 Omega Protein EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Omega Protein Main Business Overview
13.12.5 Omega Protein Latest Developments
13.13 Huatai Phrama
13.13.1 Huatai Phrama Company Information
13.13.2 Huatai Phrama EPA and DHA Product Portfolios and Specifications
13.13.3 Huatai Phrama EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Huatai Phrama Main Business Overview
13.13.5 Huatai Phrama Latest Developments
13.14 AlaskOmega (Wiley Companies)
13.14.1 AlaskOmega (Wiley Companies) Company Information
13.14.2 AlaskOmega (Wiley Companies) EPA and DHA Product Portfolios and Specifications
13.14.3 AlaskOmega (Wiley Companies) EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 AlaskOmega (Wiley Companies) Main Business Overview
13.14.5 AlaskOmega (Wiley Companies) Latest Developments
13.15 Jiangsu Auqi Marine Biotechnology
13.15.1 Jiangsu Auqi Marine Biotechnology Company Information
13.15.2 Jiangsu Auqi Marine Biotechnology EPA and DHA Product Portfolios and Specifications
13.15.3 Jiangsu Auqi Marine Biotechnology EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Auqi Marine Biotechnology Main Business Overview
13.15.5 Jiangsu Auqi Marine Biotechnology Latest Developments
13.16 Roquette
13.16.1 Roquette Company Information
13.16.2 Roquette EPA and DHA Product Portfolios and Specifications
13.16.3 Roquette EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Roquette Main Business Overview
13.16.5 Roquette Latest Developments
13.17 Polaris
13.17.1 Polaris Company Information
13.17.2 Polaris EPA and DHA Product Portfolios and Specifications
13.17.3 Polaris EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Polaris Main Business Overview
13.17.5 Polaris Latest Developments
13.18 Solutex
13.18.1 Solutex Company Information
13.18.2 Solutex EPA and DHA Product Portfolios and Specifications
13.18.3 Solutex EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Solutex Main Business Overview
13.18.5 Solutex Latest Developments
13.19 Sinomega Biotech Engineering
13.19.1 Sinomega Biotech Engineering Company Information
13.19.2 Sinomega Biotech Engineering EPA and DHA Product Portfolios and Specifications
13.19.3 Sinomega Biotech Engineering EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Sinomega Biotech Engineering Main Business Overview
13.19.5 Sinomega Biotech Engineering Latest Developments
13.20 Xinzhou Marine Biological Products
13.20.1 Xinzhou Marine Biological Products Company Information
13.20.2 Xinzhou Marine Biological Products EPA and DHA Product Portfolios and Specifications
13.20.3 Xinzhou Marine Biological Products EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Xinzhou Marine Biological Products Main Business Overview
13.20.5 Xinzhou Marine Biological Products Latest Developments
13.21 ADM
13.21.1 ADM Company Information
13.21.2 ADM EPA and DHA Product Portfolios and Specifications
13.21.3 ADM EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 ADM Main Business Overview
13.21.5 ADM Latest Developments
13.22 Nu-Mega (Clover)
13.22.1 Nu-Mega (Clover) Company Information
13.22.2 Nu-Mega (Clover) EPA and DHA Product Portfolios and Specifications
13.22.3 Nu-Mega (Clover) EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Nu-Mega (Clover) Main Business Overview
13.22.5 Nu-Mega (Clover) Latest Developments
13.23 Guangdong Runke Bioengineering
13.23.1 Guangdong Runke Bioengineering Company Information
13.23.2 Guangdong Runke Bioengineering EPA and DHA Product Portfolios and Specifications
13.23.3 Guangdong Runke Bioengineering EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Guangdong Runke Bioengineering Main Business Overview
13.23.5 Guangdong Runke Bioengineering Latest Developments
13.24 Nissui
13.24.1 Nissui Company Information
13.24.2 Nissui EPA and DHA Product Portfolios and Specifications
13.24.3 Nissui EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Nissui Main Business Overview
13.24.5 Nissui Latest Developments
13.25 Cabio Biotech
13.25.1 Cabio Biotech Company Information
13.25.2 Cabio Biotech EPA and DHA Product Portfolios and Specifications
13.25.3 Cabio Biotech EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Cabio Biotech Main Business Overview
13.25.5 Cabio Biotech Latest Developments
13.26 Skuny Bioscience
13.26.1 Skuny Bioscience Company Information
13.26.2 Skuny Bioscience EPA and DHA Product Portfolios and Specifications
13.26.3 Skuny Bioscience EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Skuny Bioscience Main Business Overview
13.26.5 Skuny Bioscience Latest Developments
13.27 Fermentalg
13.27.1 Fermentalg Company Information
13.27.2 Fermentalg EPA and DHA Product Portfolios and Specifications
13.27.3 Fermentalg EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Fermentalg Main Business Overview
13.27.5 Fermentalg Latest Developments
13.28 Renpu Pharmaceuticals
13.28.1 Renpu Pharmaceuticals Company Information
13.28.2 Renpu Pharmaceuticals EPA and DHA Product Portfolios and Specifications
13.28.3 Renpu Pharmaceuticals EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Renpu Pharmaceuticals Main Business Overview
13.28.5 Renpu Pharmaceuticals Latest Developments
13.29 Xiamen HUISON Biotech
13.29.1 Xiamen HUISON Biotech Company Information
13.29.2 Xiamen HUISON Biotech EPA and DHA Product Portfolios and Specifications
13.29.3 Xiamen HUISON Biotech EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Xiamen HUISON Biotech Main Business Overview
13.29.5 Xiamen HUISON Biotech Latest Developments
13.30 Xiamen Kingdomway
13.30.1 Xiamen Kingdomway Company Information
13.30.2 Xiamen Kingdomway EPA and DHA Product Portfolios and Specifications
13.30.3 Xiamen Kingdomway EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Xiamen Kingdomway Main Business Overview
13.30.5 Xiamen Kingdomway Latest Developments
13.31 Algarithm
13.31.1 Algarithm Company Information
13.31.2 Algarithm EPA and DHA Product Portfolios and Specifications
13.31.3 Algarithm EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 Algarithm Main Business Overview
13.31.5 Algarithm Latest Developments
13.32 Hubei Fuxing Biological Technology
13.32.1 Hubei Fuxing Biological Technology Company Information
13.32.2 Hubei Fuxing Biological Technology EPA and DHA Product Portfolios and Specifications
13.32.3 Hubei Fuxing Biological Technology EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.32.4 Hubei Fuxing Biological Technology Main Business Overview
13.32.5 Hubei Fuxing Biological Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global EPA and DHA Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for EPA and DHA by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for EPA and DHA by Country/Region, 2021, 2025 & 2032
2.2 EPA and DHA Segment by Type
2.2.1 EPA
2.2.2 DHA
2.2.3 EPA and DHA Sales by Type
2.2.3.1 Global EPA and DHA Sales Market Share by Type (2021-2026)
2.2.3.2 Global EPA and DHA Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global EPA and DHA Sale Price by Type (2021-2026)
2.3 EPA and DHA Segment by Source
2.3.1 Fish Oil EPA and DHA
2.3.2 Algae Oil EPA and DHA
2.3.3 Others
2.3.4 EPA and DHA Sales by Source
2.3.4.1 Global EPA and DHA Sales Market Share by Source (2021-2026)
2.3.4.2 Global EPA and DHA Revenue and Market Share by Source (2021-2026)
2.3.4.3 Global EPA and DHA Sale Price by Source (2021-2026)
2.4 EPA and DHA Segment by Grade
2.4.1 Food Grade
2.4.2 Pharma Grade
2.4.3 Feed Grade
2.4.4 EPA and DHA Sales by Grade
2.4.4.1 Global EPA and DHA Sales Market Share by Grade (2021-2026)
2.4.4.2 Global EPA and DHA Revenue and Market Share by Grade (2021-2026)
2.4.4.3 Global EPA and DHA Sale Price by Grade (2021-2026)
2.5 EPA and DHA Segment by Application
2.5.1 Dietary Supplements
2.5.2 Fortified Food and Beverages
2.5.3 Infant Formula
2.5.4 Pharmaceuticals
2.5.5 Pet Food
2.5.6 Others
2.5.7 EPA and DHA Sales by Application
2.5.7.1 Global EPA and DHA Sale Market Share by Application (2021-2026)
2.5.7.2 Global EPA and DHA Revenue and Market Share by Application (2021-2026)
2.5.7.3 Global EPA and DHA Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global EPA and DHA Breakdown Data by Company
3.1.1 Global EPA and DHA Annual Sales by Company (2021-2026)
3.1.2 Global EPA and DHA Sales Market Share by Company (2021-2026)
3.2 Global EPA and DHA Annual Revenue by Company (2021-2026)
3.2.1 Global EPA and DHA Revenue by Company (2021-2026)
3.2.2 Global EPA and DHA Revenue Market Share by Company (2021-2026)
3.3 Global EPA and DHA Sale Price by Company
3.4 Key Manufacturers EPA and DHA Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers EPA and DHA Product Location Distribution
3.4.2 Players EPA and DHA Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EPA AND DHA BY GEOGRAPHIC REGION
4.1 World Historic EPA and DHA Market Size by Geographic Region (2021-2026)
4.1.1 Global EPA and DHA Annual Sales by Geographic Region (2021-2026)
4.1.2 Global EPA and DHA Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic EPA and DHA Market Size by Country/Region (2021-2026)
4.2.1 Global EPA and DHA Annual Sales by Country/Region (2021-2026)
4.2.2 Global EPA and DHA Annual Revenue by Country/Region (2021-2026)
4.3 Americas EPA and DHA Sales Growth
4.4 APAC EPA and DHA Sales Growth
4.5 Europe EPA and DHA Sales Growth
4.6 Middle East & Africa EPA and DHA Sales Growth
5 AMERICAS
5.1 Americas EPA and DHA Sales by Country
5.1.1 Americas EPA and DHA Sales by Country (2021-2026)
5.1.2 Americas EPA and DHA Revenue by Country (2021-2026)
5.2 Americas EPA and DHA Sales by Type (2021-2026)
5.3 Americas EPA and DHA Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC EPA and DHA Sales by Region
6.1.1 APAC EPA and DHA Sales by Region (2021-2026)
6.1.2 APAC EPA and DHA Revenue by Region (2021-2026)
6.2 APAC EPA and DHA Sales by Type (2021-2026)
6.3 APAC EPA and DHA Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe EPA and DHA by Country
7.1.1 Europe EPA and DHA Sales by Country (2021-2026)
7.1.2 Europe EPA and DHA Revenue by Country (2021-2026)
7.2 Europe EPA and DHA Sales by Type (2021-2026)
7.3 Europe EPA and DHA Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa EPA and DHA by Country
8.1.1 Middle East & Africa EPA and DHA Sales by Country (2021-2026)
8.1.2 Middle East & Africa EPA and DHA Revenue by Country (2021-2026)
8.2 Middle East & Africa EPA and DHA Sales by Type (2021-2026)
8.3 Middle East & Africa EPA and DHA Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of EPA and DHA
10.3 Manufacturing Process Analysis of EPA and DHA
10.4 Industry Chain Structure of EPA and DHA
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 EPA and DHA Distributors
11.3 EPA and DHA Customer
12 WORLD FORECAST REVIEW FOR EPA AND DHA BY GEOGRAPHIC REGION
12.1 Global EPA and DHA Market Size Forecast by Region
12.1.1 Global EPA and DHA Forecast by Region (2027-2032)
12.1.2 Global EPA and DHA Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global EPA and DHA Forecast by Type (2027-2032)
12.7 Global EPA and DHA Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 dsm-firmenich
13.1.1 dsm-firmenich Company Information
13.1.2 dsm-firmenich EPA and DHA Product Portfolios and Specifications
13.1.3 dsm-firmenich EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 dsm-firmenich Main Business Overview
13.1.5 dsm-firmenich Latest Developments
13.2 KD Pharma
13.2.1 KD Pharma Company Information
13.2.2 KD Pharma EPA and DHA Product Portfolios and Specifications
13.2.3 KD Pharma EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 KD Pharma Main Business Overview
13.2.5 KD Pharma Latest Developments
13.3 Croda
13.3.1 Croda Company Information
13.3.2 Croda EPA and DHA Product Portfolios and Specifications
13.3.3 Croda EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Croda Main Business Overview
13.3.5 Croda Latest Developments
13.4 BASF
13.4.1 BASF Company Information
13.4.2 BASF EPA and DHA Product Portfolios and Specifications
13.4.3 BASF EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 BASF Main Business Overview
13.4.5 BASF Latest Developments
13.5 Yuwang Pharma
13.5.1 Yuwang Pharma Company Information
13.5.2 Yuwang Pharma EPA and DHA Product Portfolios and Specifications
13.5.3 Yuwang Pharma EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Yuwang Pharma Main Business Overview
13.5.5 Yuwang Pharma Latest Developments
13.6 Corbion
13.6.1 Corbion Company Information
13.6.2 Corbion EPA and DHA Product Portfolios and Specifications
13.6.3 Corbion EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Corbion Main Business Overview
13.6.5 Corbion Latest Developments
13.7 GC Rieber VivoMega
13.7.1 GC Rieber VivoMega Company Information
13.7.2 GC Rieber VivoMega EPA and DHA Product Portfolios and Specifications
13.7.3 GC Rieber VivoMega EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GC Rieber VivoMega Main Business Overview
13.7.5 GC Rieber VivoMega Latest Developments
13.8 Pelagia (EPAX)
13.8.1 Pelagia (EPAX) Company Information
13.8.2 Pelagia (EPAX) EPA and DHA Product Portfolios and Specifications
13.8.3 Pelagia (EPAX) EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Pelagia (EPAX) Main Business Overview
13.8.5 Pelagia (EPAX) Latest Developments
13.9 Golden Omega
13.9.1 Golden Omega Company Information
13.9.2 Golden Omega EPA and DHA Product Portfolios and Specifications
13.9.3 Golden Omega EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Golden Omega Main Business Overview
13.9.5 Golden Omega Latest Developments
13.10 TASA
13.10.1 TASA Company Information
13.10.2 TASA EPA and DHA Product Portfolios and Specifications
13.10.3 TASA EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 TASA Main Business Overview
13.10.5 TASA Latest Developments
13.11 KinOmega Biopharm
13.11.1 KinOmega Biopharm Company Information
13.11.2 KinOmega Biopharm EPA and DHA Product Portfolios and Specifications
13.11.3 KinOmega Biopharm EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KinOmega Biopharm Main Business Overview
13.11.5 KinOmega Biopharm Latest Developments
13.12 Omega Protein
13.12.1 Omega Protein Company Information
13.12.2 Omega Protein EPA and DHA Product Portfolios and Specifications
13.12.3 Omega Protein EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Omega Protein Main Business Overview
13.12.5 Omega Protein Latest Developments
13.13 Huatai Phrama
13.13.1 Huatai Phrama Company Information
13.13.2 Huatai Phrama EPA and DHA Product Portfolios and Specifications
13.13.3 Huatai Phrama EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Huatai Phrama Main Business Overview
13.13.5 Huatai Phrama Latest Developments
13.14 AlaskOmega (Wiley Companies)
13.14.1 AlaskOmega (Wiley Companies) Company Information
13.14.2 AlaskOmega (Wiley Companies) EPA and DHA Product Portfolios and Specifications
13.14.3 AlaskOmega (Wiley Companies) EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 AlaskOmega (Wiley Companies) Main Business Overview
13.14.5 AlaskOmega (Wiley Companies) Latest Developments
13.15 Jiangsu Auqi Marine Biotechnology
13.15.1 Jiangsu Auqi Marine Biotechnology Company Information
13.15.2 Jiangsu Auqi Marine Biotechnology EPA and DHA Product Portfolios and Specifications
13.15.3 Jiangsu Auqi Marine Biotechnology EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Jiangsu Auqi Marine Biotechnology Main Business Overview
13.15.5 Jiangsu Auqi Marine Biotechnology Latest Developments
13.16 Roquette
13.16.1 Roquette Company Information
13.16.2 Roquette EPA and DHA Product Portfolios and Specifications
13.16.3 Roquette EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Roquette Main Business Overview
13.16.5 Roquette Latest Developments
13.17 Polaris
13.17.1 Polaris Company Information
13.17.2 Polaris EPA and DHA Product Portfolios and Specifications
13.17.3 Polaris EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Polaris Main Business Overview
13.17.5 Polaris Latest Developments
13.18 Solutex
13.18.1 Solutex Company Information
13.18.2 Solutex EPA and DHA Product Portfolios and Specifications
13.18.3 Solutex EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Solutex Main Business Overview
13.18.5 Solutex Latest Developments
13.19 Sinomega Biotech Engineering
13.19.1 Sinomega Biotech Engineering Company Information
13.19.2 Sinomega Biotech Engineering EPA and DHA Product Portfolios and Specifications
13.19.3 Sinomega Biotech Engineering EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Sinomega Biotech Engineering Main Business Overview
13.19.5 Sinomega Biotech Engineering Latest Developments
13.20 Xinzhou Marine Biological Products
13.20.1 Xinzhou Marine Biological Products Company Information
13.20.2 Xinzhou Marine Biological Products EPA and DHA Product Portfolios and Specifications
13.20.3 Xinzhou Marine Biological Products EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Xinzhou Marine Biological Products Main Business Overview
13.20.5 Xinzhou Marine Biological Products Latest Developments
13.21 ADM
13.21.1 ADM Company Information
13.21.2 ADM EPA and DHA Product Portfolios and Specifications
13.21.3 ADM EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 ADM Main Business Overview
13.21.5 ADM Latest Developments
13.22 Nu-Mega (Clover)
13.22.1 Nu-Mega (Clover) Company Information
13.22.2 Nu-Mega (Clover) EPA and DHA Product Portfolios and Specifications
13.22.3 Nu-Mega (Clover) EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Nu-Mega (Clover) Main Business Overview
13.22.5 Nu-Mega (Clover) Latest Developments
13.23 Guangdong Runke Bioengineering
13.23.1 Guangdong Runke Bioengineering Company Information
13.23.2 Guangdong Runke Bioengineering EPA and DHA Product Portfolios and Specifications
13.23.3 Guangdong Runke Bioengineering EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Guangdong Runke Bioengineering Main Business Overview
13.23.5 Guangdong Runke Bioengineering Latest Developments
13.24 Nissui
13.24.1 Nissui Company Information
13.24.2 Nissui EPA and DHA Product Portfolios and Specifications
13.24.3 Nissui EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Nissui Main Business Overview
13.24.5 Nissui Latest Developments
13.25 Cabio Biotech
13.25.1 Cabio Biotech Company Information
13.25.2 Cabio Biotech EPA and DHA Product Portfolios and Specifications
13.25.3 Cabio Biotech EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Cabio Biotech Main Business Overview
13.25.5 Cabio Biotech Latest Developments
13.26 Skuny Bioscience
13.26.1 Skuny Bioscience Company Information
13.26.2 Skuny Bioscience EPA and DHA Product Portfolios and Specifications
13.26.3 Skuny Bioscience EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Skuny Bioscience Main Business Overview
13.26.5 Skuny Bioscience Latest Developments
13.27 Fermentalg
13.27.1 Fermentalg Company Information
13.27.2 Fermentalg EPA and DHA Product Portfolios and Specifications
13.27.3 Fermentalg EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Fermentalg Main Business Overview
13.27.5 Fermentalg Latest Developments
13.28 Renpu Pharmaceuticals
13.28.1 Renpu Pharmaceuticals Company Information
13.28.2 Renpu Pharmaceuticals EPA and DHA Product Portfolios and Specifications
13.28.3 Renpu Pharmaceuticals EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.28.4 Renpu Pharmaceuticals Main Business Overview
13.28.5 Renpu Pharmaceuticals Latest Developments
13.29 Xiamen HUISON Biotech
13.29.1 Xiamen HUISON Biotech Company Information
13.29.2 Xiamen HUISON Biotech EPA and DHA Product Portfolios and Specifications
13.29.3 Xiamen HUISON Biotech EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.29.4 Xiamen HUISON Biotech Main Business Overview
13.29.5 Xiamen HUISON Biotech Latest Developments
13.30 Xiamen Kingdomway
13.30.1 Xiamen Kingdomway Company Information
13.30.2 Xiamen Kingdomway EPA and DHA Product Portfolios and Specifications
13.30.3 Xiamen Kingdomway EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.30.4 Xiamen Kingdomway Main Business Overview
13.30.5 Xiamen Kingdomway Latest Developments
13.31 Algarithm
13.31.1 Algarithm Company Information
13.31.2 Algarithm EPA and DHA Product Portfolios and Specifications
13.31.3 Algarithm EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.31.4 Algarithm Main Business Overview
13.31.5 Algarithm Latest Developments
13.32 Hubei Fuxing Biological Technology
13.32.1 Hubei Fuxing Biological Technology Company Information
13.32.2 Hubei Fuxing Biological Technology EPA and DHA Product Portfolios and Specifications
13.32.3 Hubei Fuxing Biological Technology EPA and DHA Sales, Revenue, Price and Gross Margin (2021-2026)
13.32.4 Hubei Fuxing Biological Technology Main Business Overview
13.32.5 Hubei Fuxing Biological Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. EPA and DHA Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. EPA and DHA Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of EPA
Table 4. Major Players of DHA
Table 5. Global EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 6. Global EPA and DHA Sales Market Share by Type (2021-2026)
Table 7. Global EPA and DHA Revenue by Type (2021-2026) & ($ million)
Table 8. Global EPA and DHA Revenue Market Share by Type (2021-2026)
Table 9. Global EPA and DHA Sale Price by Type (2021-2026) & (US$/kg)
Table 10. Major Players of Fish Oil EPA and DHA
Table 11. Major Players of Algae Oil EPA and DHA
Table 12. Major Players of Others
Table 13. Global EPA and DHA Sales by Source (2021-2026) & (Tons)
Table 14. Global EPA and DHA Sales Market Share by Source (2021-2026)
Table 15. Global EPA and DHA Revenue by Source (2021-2026) & ($ million)
Table 16. Global EPA and DHA Revenue Market Share by Source (2021-2026)
Table 17. Global EPA and DHA Sale Price by Source (2021-2026) & (US$/kg)
Table 18. Major Players of Food Grade
Table 19. Major Players of Pharma Grade
Table 20. Major Players of Feed Grade
Table 21. Global EPA and DHA Sales by Grade (2021-2026) & (Tons)
Table 22. Global EPA and DHA Sales Market Share by Grade (2021-2026)
Table 23. Global EPA and DHA Revenue by Grade (2021-2026) & ($ million)
Table 24. Global EPA and DHA Revenue Market Share by Grade (2021-2026)
Table 25. Global EPA and DHA Sale Price by Grade (2021-2026) & (US$/kg)
Table 26. Global EPA and DHA Sale by Application (2021-2026) & (Tons)
Table 27. Global EPA and DHA Sale Market Share by Application (2021-2026)
Table 28. Global EPA and DHA Revenue by Application (2021-2026) & ($ million)
Table 29. Global EPA and DHA Revenue Market Share by Application (2021-2026)
Table 30. Global EPA and DHA Sale Price by Application (2021-2026) & (US$/kg)
Table 31. Global EPA and DHA Sales by Company (2021-2026) & (Tons)
Table 32. Global EPA and DHA Sales Market Share by Company (2021-2026)
Table 33. Global EPA and DHA Revenue by Company (2021-2026) & ($ millions)
Table 34. Global EPA and DHA Revenue Market Share by Company (2021-2026)
Table 35. Global EPA and DHA Sale Price by Company (2021-2026) & (US$/kg)
Table 36. Key Manufacturers EPA and DHA Producing Area Distribution and Sales Area
Table 37. Players EPA and DHA Products Offered
Table 38. EPA and DHA Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global EPA and DHA Sales by Geographic Region (2021-2026) & (Tons)
Table 42. Global EPA and DHA Sales Market Share Geographic Region (2021-2026)
Table 43. Global EPA and DHA Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global EPA and DHA Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global EPA and DHA Sales by Country/Region (2021-2026) & (Tons)
Table 46. Global EPA and DHA Sales Market Share by Country/Region (2021-2026)
Table 47. Global EPA and DHA Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global EPA and DHA Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas EPA and DHA Sales by Country (2021-2026) & (Tons)
Table 50. Americas EPA and DHA Sales Market Share by Country (2021-2026)
Table 51. Americas EPA and DHA Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 53. Americas EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 54. APAC EPA and DHA Sales by Region (2021-2026) & (Tons)
Table 55. APAC EPA and DHA Sales Market Share by Region (2021-2026)
Table 56. APAC EPA and DHA Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 58. APAC EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 59. Europe EPA and DHA Sales by Country (2021-2026) & (Tons)
Table 60. Europe EPA and DHA Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 62. Europe EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 63. Middle East & Africa EPA and DHA Sales by Country (2021-2026) & (Tons)
Table 64. Middle East & Africa EPA and DHA Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 66. Middle East & Africa EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 67. Key Market Drivers & Growth Opportunities of EPA and DHA
Table 68. Key Market Challenges & Risks of EPA and DHA
Table 69. Key Industry Trends of EPA and DHA
Table 70. EPA and DHA Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. EPA and DHA Distributors List
Table 73. EPA and DHA Customer List
Table 74. Global EPA and DHA Sales Forecast by Region (2027-2032) & (Tons)
Table 75. Global EPA and DHA Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas EPA and DHA Sales Forecast by Country (2027-2032) & (Tons)
Table 77. Americas EPA and DHA Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC EPA and DHA Sales Forecast by Region (2027-2032) & (Tons)
Table 79. APAC EPA and DHA Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe EPA and DHA Sales Forecast by Country (2027-2032) & (Tons)
Table 81. Europe EPA and DHA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa EPA and DHA Sales Forecast by Country (2027-2032) & (Tons)
Table 83. Middle East & Africa EPA and DHA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global EPA and DHA Sales Forecast by Type (2027-2032) & (Tons)
Table 85. Global EPA and DHA Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global EPA and DHA Sales Forecast by Application (2027-2032) & (Tons)
Table 87. Global EPA and DHA Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. dsm-firmenich Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 89. dsm-firmenich EPA and DHA Product Portfolios and Specifications
Table 90. dsm-firmenich EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 91. dsm-firmenich Main Business
Table 92. dsm-firmenich Latest Developments
Table 93. KD Pharma Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 94. KD Pharma EPA and DHA Product Portfolios and Specifications
Table 95. KD Pharma EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. KD Pharma Main Business
Table 97. KD Pharma Latest Developments
Table 98. Croda Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 99. Croda EPA and DHA Product Portfolios and Specifications
Table 100. Croda EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Croda Main Business
Table 102. Croda Latest Developments
Table 103. BASF Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 104. BASF EPA and DHA Product Portfolios and Specifications
Table 105. BASF EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. BASF Main Business
Table 107. BASF Latest Developments
Table 108. Yuwang Pharma Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 109. Yuwang Pharma EPA and DHA Product Portfolios and Specifications
Table 110. Yuwang Pharma EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. Yuwang Pharma Main Business
Table 112. Yuwang Pharma Latest Developments
Table 113. Corbion Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 114. Corbion EPA and DHA Product Portfolios and Specifications
Table 115. Corbion EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. Corbion Main Business
Table 117. Corbion Latest Developments
Table 118. GC Rieber VivoMega Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 119. GC Rieber VivoMega EPA and DHA Product Portfolios and Specifications
Table 120. GC Rieber VivoMega EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. GC Rieber VivoMega Main Business
Table 122. GC Rieber VivoMega Latest Developments
Table 123. Pelagia (EPAX) Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 124. Pelagia (EPAX) EPA and DHA Product Portfolios and Specifications
Table 125. Pelagia (EPAX) EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 126. Pelagia (EPAX) Main Business
Table 127. Pelagia (EPAX) Latest Developments
Table 128. Golden Omega Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 129. Golden Omega EPA and DHA Product Portfolios and Specifications
Table 130. Golden Omega EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 131. Golden Omega Main Business
Table 132. Golden Omega Latest Developments
Table 133. TASA Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 134. TASA EPA and DHA Product Portfolios and Specifications
Table 135. TASA EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 136. TASA Main Business
Table 137. TASA Latest Developments
Table 138. KinOmega Biopharm Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 139. KinOmega Biopharm EPA and DHA Product Portfolios and Specifications
Table 140. KinOmega Biopharm EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 141. KinOmega Biopharm Main Business
Table 142. KinOmega Biopharm Latest Developments
Table 143. Omega Protein Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 144. Omega Protein EPA and DHA Product Portfolios and Specifications
Table 145. Omega Protein EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 146. Omega Protein Main Business
Table 147. Omega Protein Latest Developments
Table 148. Huatai Phrama Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 149. Huatai Phrama EPA and DHA Product Portfolios and Specifications
Table 150. Huatai Phrama EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 151. Huatai Phrama Main Business
Table 152. Huatai Phrama Latest Developments
Table 153. AlaskOmega (Wiley Companies) Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 154. AlaskOmega (Wiley Companies) EPA and DHA Product Portfolios and Specifications
Table 155. AlaskOmega (Wiley Companies) EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 156. AlaskOmega (Wiley Companies) Main Business
Table 157. AlaskOmega (Wiley Companies) Latest Developments
Table 158. Jiangsu Auqi Marine Biotechnology Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Auqi Marine Biotechnology EPA and DHA Product Portfolios and Specifications
Table 160. Jiangsu Auqi Marine Biotechnology EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 161. Jiangsu Auqi Marine Biotechnology Main Business
Table 162. Jiangsu Auqi Marine Biotechnology Latest Developments
Table 163. Roquette Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 164. Roquette EPA and DHA Product Portfolios and Specifications
Table 165. Roquette EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 166. Roquette Main Business
Table 167. Roquette Latest Developments
Table 168. Polaris Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 169. Polaris EPA and DHA Product Portfolios and Specifications
Table 170. Polaris EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 171. Polaris Main Business
Table 172. Polaris Latest Developments
Table 173. Solutex Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 174. Solutex EPA and DHA Product Portfolios and Specifications
Table 175. Solutex EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 176. Solutex Main Business
Table 177. Solutex Latest Developments
Table 178. Sinomega Biotech Engineering Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 179. Sinomega Biotech Engineering EPA and DHA Product Portfolios and Specifications
Table 180. Sinomega Biotech Engineering EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 181. Sinomega Biotech Engineering Main Business
Table 182. Sinomega Biotech Engineering Latest Developments
Table 183. Xinzhou Marine Biological Products Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 184. Xinzhou Marine Biological Products EPA and DHA Product Portfolios and Specifications
Table 185. Xinzhou Marine Biological Products EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 186. Xinzhou Marine Biological Products Main Business
Table 187. Xinzhou Marine Biological Products Latest Developments
Table 188. ADM Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 189. ADM EPA and DHA Product Portfolios and Specifications
Table 190. ADM EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 191. ADM Main Business
Table 192. ADM Latest Developments
Table 193. Nu-Mega (Clover) Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 194. Nu-Mega (Clover) EPA and DHA Product Portfolios and Specifications
Table 195. Nu-Mega (Clover) EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 196. Nu-Mega (Clover) Main Business
Table 197. Nu-Mega (Clover) Latest Developments
Table 198. Guangdong Runke Bioengineering Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 199. Guangdong Runke Bioengineering EPA and DHA Product Portfolios and Specifications
Table 200. Guangdong Runke Bioengineering EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 201. Guangdong Runke Bioengineering Main Business
Table 202. Guangdong Runke Bioengineering Latest Developments
Table 203. Nissui Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 204. Nissui EPA and DHA Product Portfolios and Specifications
Table 205. Nissui EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 206. Nissui Main Business
Table 207. Nissui Latest Developments
Table 208. Cabio Biotech Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 209. Cabio Biotech EPA and DHA Product Portfolios and Specifications
Table 210. Cabio Biotech EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 211. Cabio Biotech Main Business
Table 212. Cabio Biotech Latest Developments
Table 213. Skuny Bioscience Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 214. Skuny Bioscience EPA and DHA Product Portfolios and Specifications
Table 215. Skuny Bioscience EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 216. Skuny Bioscience Main Business
Table 217. Skuny Bioscience Latest Developments
Table 218. Fermentalg Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 219. Fermentalg EPA and DHA Product Portfolios and Specifications
Table 220. Fermentalg EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 221. Fermentalg Main Business
Table 222. Fermentalg Latest Developments
Table 223. Renpu Pharmaceuticals Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 224. Renpu Pharmaceuticals EPA and DHA Product Portfolios and Specifications
Table 225. Renpu Pharmaceuticals EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 226. Renpu Pharmaceuticals Main Business
Table 227. Renpu Pharmaceuticals Latest Developments
Table 228. Xiamen HUISON Biotech Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 229. Xiamen HUISON Biotech EPA and DHA Product Portfolios and Specifications
Table 230. Xiamen HUISON Biotech EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 231. Xiamen HUISON Biotech Main Business
Table 232. Xiamen HUISON Biotech Latest Developments
Table 233. Xiamen Kingdomway Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 234. Xiamen Kingdomway EPA and DHA Product Portfolios and Specifications
Table 235. Xiamen Kingdomway EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 236. Xiamen Kingdomway Main Business
Table 237. Xiamen Kingdomway Latest Developments
Table 238. Algarithm Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 239. Algarithm EPA and DHA Product Portfolios and Specifications
Table 240. Algarithm EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 241. Algarithm Main Business
Table 242. Algarithm Latest Developments
Table 243. Hubei Fuxing Biological Technology Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 244. Hubei Fuxing Biological Technology EPA and DHA Product Portfolios and Specifications
Table 245. Hubei Fuxing Biological Technology EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 246. Hubei Fuxing Biological Technology Main Business
Table 247. Hubei Fuxing Biological Technology Latest Developments
Table 1. EPA and DHA Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. EPA and DHA Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of EPA
Table 4. Major Players of DHA
Table 5. Global EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 6. Global EPA and DHA Sales Market Share by Type (2021-2026)
Table 7. Global EPA and DHA Revenue by Type (2021-2026) & ($ million)
Table 8. Global EPA and DHA Revenue Market Share by Type (2021-2026)
Table 9. Global EPA and DHA Sale Price by Type (2021-2026) & (US$/kg)
Table 10. Major Players of Fish Oil EPA and DHA
Table 11. Major Players of Algae Oil EPA and DHA
Table 12. Major Players of Others
Table 13. Global EPA and DHA Sales by Source (2021-2026) & (Tons)
Table 14. Global EPA and DHA Sales Market Share by Source (2021-2026)
Table 15. Global EPA and DHA Revenue by Source (2021-2026) & ($ million)
Table 16. Global EPA and DHA Revenue Market Share by Source (2021-2026)
Table 17. Global EPA and DHA Sale Price by Source (2021-2026) & (US$/kg)
Table 18. Major Players of Food Grade
Table 19. Major Players of Pharma Grade
Table 20. Major Players of Feed Grade
Table 21. Global EPA and DHA Sales by Grade (2021-2026) & (Tons)
Table 22. Global EPA and DHA Sales Market Share by Grade (2021-2026)
Table 23. Global EPA and DHA Revenue by Grade (2021-2026) & ($ million)
Table 24. Global EPA and DHA Revenue Market Share by Grade (2021-2026)
Table 25. Global EPA and DHA Sale Price by Grade (2021-2026) & (US$/kg)
Table 26. Global EPA and DHA Sale by Application (2021-2026) & (Tons)
Table 27. Global EPA and DHA Sale Market Share by Application (2021-2026)
Table 28. Global EPA and DHA Revenue by Application (2021-2026) & ($ million)
Table 29. Global EPA and DHA Revenue Market Share by Application (2021-2026)
Table 30. Global EPA and DHA Sale Price by Application (2021-2026) & (US$/kg)
Table 31. Global EPA and DHA Sales by Company (2021-2026) & (Tons)
Table 32. Global EPA and DHA Sales Market Share by Company (2021-2026)
Table 33. Global EPA and DHA Revenue by Company (2021-2026) & ($ millions)
Table 34. Global EPA and DHA Revenue Market Share by Company (2021-2026)
Table 35. Global EPA and DHA Sale Price by Company (2021-2026) & (US$/kg)
Table 36. Key Manufacturers EPA and DHA Producing Area Distribution and Sales Area
Table 37. Players EPA and DHA Products Offered
Table 38. EPA and DHA Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 39. New Products and Potential Entrants
Table 40. Market M&A Activity & Strategy
Table 41. Global EPA and DHA Sales by Geographic Region (2021-2026) & (Tons)
Table 42. Global EPA and DHA Sales Market Share Geographic Region (2021-2026)
Table 43. Global EPA and DHA Revenue by Geographic Region (2021-2026) & ($ millions)
Table 44. Global EPA and DHA Revenue Market Share by Geographic Region (2021-2026)
Table 45. Global EPA and DHA Sales by Country/Region (2021-2026) & (Tons)
Table 46. Global EPA and DHA Sales Market Share by Country/Region (2021-2026)
Table 47. Global EPA and DHA Revenue by Country/Region (2021-2026) & ($ millions)
Table 48. Global EPA and DHA Revenue Market Share by Country/Region (2021-2026)
Table 49. Americas EPA and DHA Sales by Country (2021-2026) & (Tons)
Table 50. Americas EPA and DHA Sales Market Share by Country (2021-2026)
Table 51. Americas EPA and DHA Revenue by Country (2021-2026) & ($ millions)
Table 52. Americas EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 53. Americas EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 54. APAC EPA and DHA Sales by Region (2021-2026) & (Tons)
Table 55. APAC EPA and DHA Sales Market Share by Region (2021-2026)
Table 56. APAC EPA and DHA Revenue by Region (2021-2026) & ($ millions)
Table 57. APAC EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 58. APAC EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 59. Europe EPA and DHA Sales by Country (2021-2026) & (Tons)
Table 60. Europe EPA and DHA Revenue by Country (2021-2026) & ($ millions)
Table 61. Europe EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 62. Europe EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 63. Middle East & Africa EPA and DHA Sales by Country (2021-2026) & (Tons)
Table 64. Middle East & Africa EPA and DHA Revenue Market Share by Country (2021-2026)
Table 65. Middle East & Africa EPA and DHA Sales by Type (2021-2026) & (Tons)
Table 66. Middle East & Africa EPA and DHA Sales by Application (2021-2026) & (Tons)
Table 67. Key Market Drivers & Growth Opportunities of EPA and DHA
Table 68. Key Market Challenges & Risks of EPA and DHA
Table 69. Key Industry Trends of EPA and DHA
Table 70. EPA and DHA Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. EPA and DHA Distributors List
Table 73. EPA and DHA Customer List
Table 74. Global EPA and DHA Sales Forecast by Region (2027-2032) & (Tons)
Table 75. Global EPA and DHA Revenue Forecast by Region (2027-2032) & ($ millions)
Table 76. Americas EPA and DHA Sales Forecast by Country (2027-2032) & (Tons)
Table 77. Americas EPA and DHA Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. APAC EPA and DHA Sales Forecast by Region (2027-2032) & (Tons)
Table 79. APAC EPA and DHA Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Europe EPA and DHA Sales Forecast by Country (2027-2032) & (Tons)
Table 81. Europe EPA and DHA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Middle East & Africa EPA and DHA Sales Forecast by Country (2027-2032) & (Tons)
Table 83. Middle East & Africa EPA and DHA Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Global EPA and DHA Sales Forecast by Type (2027-2032) & (Tons)
Table 85. Global EPA and DHA Revenue Forecast by Type (2027-2032) & ($ millions)
Table 86. Global EPA and DHA Sales Forecast by Application (2027-2032) & (Tons)
Table 87. Global EPA and DHA Revenue Forecast by Application (2027-2032) & ($ millions)
Table 88. dsm-firmenich Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 89. dsm-firmenich EPA and DHA Product Portfolios and Specifications
Table 90. dsm-firmenich EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 91. dsm-firmenich Main Business
Table 92. dsm-firmenich Latest Developments
Table 93. KD Pharma Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 94. KD Pharma EPA and DHA Product Portfolios and Specifications
Table 95. KD Pharma EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. KD Pharma Main Business
Table 97. KD Pharma Latest Developments
Table 98. Croda Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 99. Croda EPA and DHA Product Portfolios and Specifications
Table 100. Croda EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Croda Main Business
Table 102. Croda Latest Developments
Table 103. BASF Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 104. BASF EPA and DHA Product Portfolios and Specifications
Table 105. BASF EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. BASF Main Business
Table 107. BASF Latest Developments
Table 108. Yuwang Pharma Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 109. Yuwang Pharma EPA and DHA Product Portfolios and Specifications
Table 110. Yuwang Pharma EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. Yuwang Pharma Main Business
Table 112. Yuwang Pharma Latest Developments
Table 113. Corbion Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 114. Corbion EPA and DHA Product Portfolios and Specifications
Table 115. Corbion EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. Corbion Main Business
Table 117. Corbion Latest Developments
Table 118. GC Rieber VivoMega Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 119. GC Rieber VivoMega EPA and DHA Product Portfolios and Specifications
Table 120. GC Rieber VivoMega EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. GC Rieber VivoMega Main Business
Table 122. GC Rieber VivoMega Latest Developments
Table 123. Pelagia (EPAX) Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 124. Pelagia (EPAX) EPA and DHA Product Portfolios and Specifications
Table 125. Pelagia (EPAX) EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 126. Pelagia (EPAX) Main Business
Table 127. Pelagia (EPAX) Latest Developments
Table 128. Golden Omega Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 129. Golden Omega EPA and DHA Product Portfolios and Specifications
Table 130. Golden Omega EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 131. Golden Omega Main Business
Table 132. Golden Omega Latest Developments
Table 133. TASA Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 134. TASA EPA and DHA Product Portfolios and Specifications
Table 135. TASA EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 136. TASA Main Business
Table 137. TASA Latest Developments
Table 138. KinOmega Biopharm Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 139. KinOmega Biopharm EPA and DHA Product Portfolios and Specifications
Table 140. KinOmega Biopharm EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 141. KinOmega Biopharm Main Business
Table 142. KinOmega Biopharm Latest Developments
Table 143. Omega Protein Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 144. Omega Protein EPA and DHA Product Portfolios and Specifications
Table 145. Omega Protein EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 146. Omega Protein Main Business
Table 147. Omega Protein Latest Developments
Table 148. Huatai Phrama Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 149. Huatai Phrama EPA and DHA Product Portfolios and Specifications
Table 150. Huatai Phrama EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 151. Huatai Phrama Main Business
Table 152. Huatai Phrama Latest Developments
Table 153. AlaskOmega (Wiley Companies) Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 154. AlaskOmega (Wiley Companies) EPA and DHA Product Portfolios and Specifications
Table 155. AlaskOmega (Wiley Companies) EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 156. AlaskOmega (Wiley Companies) Main Business
Table 157. AlaskOmega (Wiley Companies) Latest Developments
Table 158. Jiangsu Auqi Marine Biotechnology Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 159. Jiangsu Auqi Marine Biotechnology EPA and DHA Product Portfolios and Specifications
Table 160. Jiangsu Auqi Marine Biotechnology EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 161. Jiangsu Auqi Marine Biotechnology Main Business
Table 162. Jiangsu Auqi Marine Biotechnology Latest Developments
Table 163. Roquette Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 164. Roquette EPA and DHA Product Portfolios and Specifications
Table 165. Roquette EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 166. Roquette Main Business
Table 167. Roquette Latest Developments
Table 168. Polaris Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 169. Polaris EPA and DHA Product Portfolios and Specifications
Table 170. Polaris EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 171. Polaris Main Business
Table 172. Polaris Latest Developments
Table 173. Solutex Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 174. Solutex EPA and DHA Product Portfolios and Specifications
Table 175. Solutex EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 176. Solutex Main Business
Table 177. Solutex Latest Developments
Table 178. Sinomega Biotech Engineering Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 179. Sinomega Biotech Engineering EPA and DHA Product Portfolios and Specifications
Table 180. Sinomega Biotech Engineering EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 181. Sinomega Biotech Engineering Main Business
Table 182. Sinomega Biotech Engineering Latest Developments
Table 183. Xinzhou Marine Biological Products Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 184. Xinzhou Marine Biological Products EPA and DHA Product Portfolios and Specifications
Table 185. Xinzhou Marine Biological Products EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 186. Xinzhou Marine Biological Products Main Business
Table 187. Xinzhou Marine Biological Products Latest Developments
Table 188. ADM Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 189. ADM EPA and DHA Product Portfolios and Specifications
Table 190. ADM EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 191. ADM Main Business
Table 192. ADM Latest Developments
Table 193. Nu-Mega (Clover) Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 194. Nu-Mega (Clover) EPA and DHA Product Portfolios and Specifications
Table 195. Nu-Mega (Clover) EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 196. Nu-Mega (Clover) Main Business
Table 197. Nu-Mega (Clover) Latest Developments
Table 198. Guangdong Runke Bioengineering Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 199. Guangdong Runke Bioengineering EPA and DHA Product Portfolios and Specifications
Table 200. Guangdong Runke Bioengineering EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 201. Guangdong Runke Bioengineering Main Business
Table 202. Guangdong Runke Bioengineering Latest Developments
Table 203. Nissui Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 204. Nissui EPA and DHA Product Portfolios and Specifications
Table 205. Nissui EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 206. Nissui Main Business
Table 207. Nissui Latest Developments
Table 208. Cabio Biotech Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 209. Cabio Biotech EPA and DHA Product Portfolios and Specifications
Table 210. Cabio Biotech EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 211. Cabio Biotech Main Business
Table 212. Cabio Biotech Latest Developments
Table 213. Skuny Bioscience Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 214. Skuny Bioscience EPA and DHA Product Portfolios and Specifications
Table 215. Skuny Bioscience EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 216. Skuny Bioscience Main Business
Table 217. Skuny Bioscience Latest Developments
Table 218. Fermentalg Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 219. Fermentalg EPA and DHA Product Portfolios and Specifications
Table 220. Fermentalg EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 221. Fermentalg Main Business
Table 222. Fermentalg Latest Developments
Table 223. Renpu Pharmaceuticals Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 224. Renpu Pharmaceuticals EPA and DHA Product Portfolios and Specifications
Table 225. Renpu Pharmaceuticals EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 226. Renpu Pharmaceuticals Main Business
Table 227. Renpu Pharmaceuticals Latest Developments
Table 228. Xiamen HUISON Biotech Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 229. Xiamen HUISON Biotech EPA and DHA Product Portfolios and Specifications
Table 230. Xiamen HUISON Biotech EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 231. Xiamen HUISON Biotech Main Business
Table 232. Xiamen HUISON Biotech Latest Developments
Table 233. Xiamen Kingdomway Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 234. Xiamen Kingdomway EPA and DHA Product Portfolios and Specifications
Table 235. Xiamen Kingdomway EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 236. Xiamen Kingdomway Main Business
Table 237. Xiamen Kingdomway Latest Developments
Table 238. Algarithm Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 239. Algarithm EPA and DHA Product Portfolios and Specifications
Table 240. Algarithm EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 241. Algarithm Main Business
Table 242. Algarithm Latest Developments
Table 243. Hubei Fuxing Biological Technology Basic Information, EPA and DHA Manufacturing Base, Sales Area and Its Competitors
Table 244. Hubei Fuxing Biological Technology EPA and DHA Product Portfolios and Specifications
Table 245. Hubei Fuxing Biological Technology EPA and DHA Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 246. Hubei Fuxing Biological Technology Main Business
Table 247. Hubei Fuxing Biological Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of EPA and DHA
Figure 2. EPA and DHA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EPA and DHA Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global EPA and DHA Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. EPA and DHA Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. EPA and DHA Sales Market Share by Country/Region (2025)
Figure 10. EPA and DHA Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of EPA
Figure 12. Product Picture of DHA
Figure 13. Global EPA and DHA Sales Market Share by Type in 2026
Figure 14. Global EPA and DHA Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Fish Oil EPA and DHA
Figure 16. Product Picture of Algae Oil EPA and DHA
Figure 17. Product Picture of Others
Figure 18. Global EPA and DHA Sales Market Share by Source in 2026
Figure 19. Global EPA and DHA Revenue Market Share by Source (2021-2026)
Figure 20. Product Picture of Food Grade
Figure 21. Product Picture of Pharma Grade
Figure 22. Product Picture of Feed Grade
Figure 23. Global EPA and DHA Sales Market Share by Grade in 2026
Figure 24. Global EPA and DHA Revenue Market Share by Grade (2021-2026)
Figure 25. EPA and DHA Consumed in Dietary Supplements
Figure 26. Global EPA and DHA Market: Dietary Supplements (2021-2026) & (Tons)
Figure 27. EPA and DHA Consumed in Fortified Food and Beverages
Figure 28. Global EPA and DHA Market: Fortified Food and Beverages (2021-2026) & (Tons)
Figure 29. EPA and DHA Consumed in Infant Formula
Figure 30. Global EPA and DHA Market: Infant Formula (2021-2026) & (Tons)
Figure 31. EPA and DHA Consumed in Pharmaceuticals
Figure 32. Global EPA and DHA Market: Pharmaceuticals (2021-2026) & (Tons)
Figure 33. EPA and DHA Consumed in Pet Food
Figure 34. Global EPA and DHA Market: Pet Food (2021-2026) & (Tons)
Figure 35. EPA and DHA Consumed in Others
Figure 36. Global EPA and DHA Market: Others (2021-2026) & (Tons)
Figure 37. Global EPA and DHA Sale Market Share by Application (2025)
Figure 38. Global EPA and DHA Revenue Market Share by Application in 2025
Figure 39. EPA and DHA Sales by Company in 2025 (Tons)
Figure 40. Global EPA and DHA Sales Market Share by Company in 2025
Figure 41. EPA and DHA Revenue by Company in 2025 ($ millions)
Figure 42. Global EPA and DHA Revenue Market Share by Company in 2025
Figure 43. Global EPA and DHA Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global EPA and DHA Revenue Market Share by Geographic Region in 2025
Figure 45. Americas EPA and DHA Sales 2021-2026 (Tons)
Figure 46. Americas EPA and DHA Revenue 2021-2026 ($ millions)
Figure 47. APAC EPA and DHA Sales 2021-2026 (Tons)
Figure 48. APAC EPA and DHA Revenue 2021-2026 ($ millions)
Figure 49. Europe EPA and DHA Sales 2021-2026 (Tons)
Figure 50. Europe EPA and DHA Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa EPA and DHA Sales 2021-2026 (Tons)
Figure 52. Middle East & Africa EPA and DHA Revenue 2021-2026 ($ millions)
Figure 53. Americas EPA and DHA Sales Market Share by Country in 2025
Figure 54. Americas EPA and DHA Revenue Market Share by Country (2021-2026)
Figure 55. Americas EPA and DHA Sales Market Share by Type (2021-2026)
Figure 56. Americas EPA and DHA Sales Market Share by Application (2021-2026)
Figure 57. United States EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC EPA and DHA Sales Market Share by Region in 2025
Figure 62. APAC EPA and DHA Revenue Market Share by Region (2021-2026)
Figure 63. APAC EPA and DHA Sales Market Share by Type (2021-2026)
Figure 64. APAC EPA and DHA Sales Market Share by Application (2021-2026)
Figure 65. China EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 69. India EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe EPA and DHA Sales Market Share by Country in 2025
Figure 73. Europe EPA and DHA Revenue Market Share by Country (2021-2026)
Figure 74. Europe EPA and DHA Sales Market Share by Type (2021-2026)
Figure 75. Europe EPA and DHA Sales Market Share by Application (2021-2026)
Figure 76. Germany EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 77. France EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 78. UK EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa EPA and DHA Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa EPA and DHA Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa EPA and DHA Sales Market Share by Application (2021-2026)
Figure 84. Egypt EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of EPA and DHA in 2026
Figure 90. Manufacturing Process Analysis of EPA and DHA
Figure 91. Industry Chain Structure of EPA and DHA
Figure 92. Channels of Distribution
Figure 93. Global EPA and DHA Sales Market Forecast by Region (2027-2032)
Figure 94. Global EPA and DHA Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global EPA and DHA Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global EPA and DHA Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global EPA and DHA Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global EPA and DHA Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of EPA and DHA
Figure 2. EPA and DHA Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EPA and DHA Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global EPA and DHA Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. EPA and DHA Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. EPA and DHA Sales Market Share by Country/Region (2025)
Figure 10. EPA and DHA Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of EPA
Figure 12. Product Picture of DHA
Figure 13. Global EPA and DHA Sales Market Share by Type in 2026
Figure 14. Global EPA and DHA Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Fish Oil EPA and DHA
Figure 16. Product Picture of Algae Oil EPA and DHA
Figure 17. Product Picture of Others
Figure 18. Global EPA and DHA Sales Market Share by Source in 2026
Figure 19. Global EPA and DHA Revenue Market Share by Source (2021-2026)
Figure 20. Product Picture of Food Grade
Figure 21. Product Picture of Pharma Grade
Figure 22. Product Picture of Feed Grade
Figure 23. Global EPA and DHA Sales Market Share by Grade in 2026
Figure 24. Global EPA and DHA Revenue Market Share by Grade (2021-2026)
Figure 25. EPA and DHA Consumed in Dietary Supplements
Figure 26. Global EPA and DHA Market: Dietary Supplements (2021-2026) & (Tons)
Figure 27. EPA and DHA Consumed in Fortified Food and Beverages
Figure 28. Global EPA and DHA Market: Fortified Food and Beverages (2021-2026) & (Tons)
Figure 29. EPA and DHA Consumed in Infant Formula
Figure 30. Global EPA and DHA Market: Infant Formula (2021-2026) & (Tons)
Figure 31. EPA and DHA Consumed in Pharmaceuticals
Figure 32. Global EPA and DHA Market: Pharmaceuticals (2021-2026) & (Tons)
Figure 33. EPA and DHA Consumed in Pet Food
Figure 34. Global EPA and DHA Market: Pet Food (2021-2026) & (Tons)
Figure 35. EPA and DHA Consumed in Others
Figure 36. Global EPA and DHA Market: Others (2021-2026) & (Tons)
Figure 37. Global EPA and DHA Sale Market Share by Application (2025)
Figure 38. Global EPA and DHA Revenue Market Share by Application in 2025
Figure 39. EPA and DHA Sales by Company in 2025 (Tons)
Figure 40. Global EPA and DHA Sales Market Share by Company in 2025
Figure 41. EPA and DHA Revenue by Company in 2025 ($ millions)
Figure 42. Global EPA and DHA Revenue Market Share by Company in 2025
Figure 43. Global EPA and DHA Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global EPA and DHA Revenue Market Share by Geographic Region in 2025
Figure 45. Americas EPA and DHA Sales 2021-2026 (Tons)
Figure 46. Americas EPA and DHA Revenue 2021-2026 ($ millions)
Figure 47. APAC EPA and DHA Sales 2021-2026 (Tons)
Figure 48. APAC EPA and DHA Revenue 2021-2026 ($ millions)
Figure 49. Europe EPA and DHA Sales 2021-2026 (Tons)
Figure 50. Europe EPA and DHA Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa EPA and DHA Sales 2021-2026 (Tons)
Figure 52. Middle East & Africa EPA and DHA Revenue 2021-2026 ($ millions)
Figure 53. Americas EPA and DHA Sales Market Share by Country in 2025
Figure 54. Americas EPA and DHA Revenue Market Share by Country (2021-2026)
Figure 55. Americas EPA and DHA Sales Market Share by Type (2021-2026)
Figure 56. Americas EPA and DHA Sales Market Share by Application (2021-2026)
Figure 57. United States EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC EPA and DHA Sales Market Share by Region in 2025
Figure 62. APAC EPA and DHA Revenue Market Share by Region (2021-2026)
Figure 63. APAC EPA and DHA Sales Market Share by Type (2021-2026)
Figure 64. APAC EPA and DHA Sales Market Share by Application (2021-2026)
Figure 65. China EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 69. India EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe EPA and DHA Sales Market Share by Country in 2025
Figure 73. Europe EPA and DHA Revenue Market Share by Country (2021-2026)
Figure 74. Europe EPA and DHA Sales Market Share by Type (2021-2026)
Figure 75. Europe EPA and DHA Sales Market Share by Application (2021-2026)
Figure 76. Germany EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 77. France EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 78. UK EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa EPA and DHA Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa EPA and DHA Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa EPA and DHA Sales Market Share by Application (2021-2026)
Figure 84. Egypt EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries EPA and DHA Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of EPA and DHA in 2026
Figure 90. Manufacturing Process Analysis of EPA and DHA
Figure 91. Industry Chain Structure of EPA and DHA
Figure 92. Channels of Distribution
Figure 93. Global EPA and DHA Sales Market Forecast by Region (2027-2032)
Figure 94. Global EPA and DHA Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global EPA and DHA Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global EPA and DHA Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global EPA and DHA Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global EPA and DHA Revenue Market Share Forecast by Application (2027-2032)
